Potential Mutagenic Impurity (GTI) Assessments
Using a range of different software tools, Arcinova has the necessary expertise to assess the mutagenic potential of impurities and degradation products from drug substance and drug product manufacture, which is required for successful regulatory submissions and to comply with ICH M7 guidance,
Some impurities, which are highly reactive because of their structure, have the potential to interact with DNA.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationThe annual dinner meeting and innovation celebration will be attended by Masha Kononov, Senior Director Emerging Pharma US.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationDates: 7th FebruaryLocation: New Brunswick, NJ
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 16th - 17th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany